// App-Quantinova.ai

: Genomic Determinants of Response to Blinatumomab in Relapsed/Refractory (R/R) B-Cell Precursor Acute Lymphoblastic Leukemia in Adults

Researchers

Presenter

  • Yaqi Zhao

Principal Investigators

  • Ibrahim Aldoss

  • Chunxu Qu

  • Guido Marcucci

  • Anthony S. Stein

  • Ravi Bhatia

  • Charles G. Mullighan

  • Stephen J Forman

  • Kathryn G. Roberts

Medical Centers

  • St. Jude Children's Research Hospital, Memphis, TN

  • Department of pathology, City of Hope National Medical Center, Duarte, CA.

  • Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Blinatumomab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved